Berkshire Hathaway (NYSE: BRK-A ) (NYSE: BRK-B ) subsidiary Brooks Sports is drawing quite a bit of attention from Buffett devotees these days. The running shoe maker has sprinted to 34% volume growth in both 2011 and 2012, with U.S. sales growth hitting the tape at 43% by the end of last year.
Our roving reporter Rex Moore caught up with Brooks CEO Jim Weber at the recent Berkshire shareholder meeting in Omaha. In this segment of a multipart series, Jim talks about the advantages of working with Warren Buffett.
Is Berkshire for you?
Thanks to the savvy of investing legend Warren Buffett, Berkshire Hathaway's book value per share has grown a mind-blowing 586,817% over the past 48 years. But with Buffett aging and Berkshire rapidly evolving, is this insurance conglomerate still a buy today? In The Motley Fool's premium report on the company, Berkshire expert Joe Magyer provides investors with key reasons to buy as well as important risks to watch out for. Click here now for instant access to Joe's take on Berkshire!
10 Best Warren Buffett Stocks To Invest In Right Now: SPDR DB International Government Inflation-Protected Bond ETF (WIP)
SPDR DB International Government Inflation-Protected Bond ETF (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of the DB Global Government ex-US Inflation-Linked Bond Capped Index (the Index). The Index measures the performance of the inflation-linked government bond markets of developed and emerging market countries outside of the United States. Inflation protected public obligations of the inflation-linked government bond markets of developed and emerging market countries, commonly known in the United States as treasury inflation-protected securities (TIPS), are securities issued by such governments that are designed to provide inflation protection to investors. The Fund uses a passive management strategy to track the Index. The Fund�� investment advisor is SSgA Funds Management, Inc. Advisors' Opinion:- [By Richard Stavros]
With respect to inflation protected bonds, though TIPS should be a part of every portfolio. However, we believe the SPDR DB International Government Inflation-Protected Bond (WIP) offers greater protection than TIPS.
Top 5 Warren Buffett Stocks To Invest In Right Now: Pimco Corporate & Income Opportunity Fund (PTY)
PIMCO Corporate Opportunity Fund (the Fund) is a diversified closed-end management investment company. The Fund�� investment objective is to seek maximum total return through a combination of current income and capital appreciation in a diversified portfolio of United States dollar-denominated corporate debt obligations of varying maturities and other income producing securities. The Fund will normally focus on corporate debt obligations rated in the lowest investment-grade category (Baa or BBB) and in the highest non-investment-grade category (Ba or BB). Its portfolio includes corporate bonds and notes, the United States Government agency securities, sovereign debt obligations, municipal bonds, mortgage-backed securities, asset-backed securities and short-term investments.
The Fund invests in residual interest municipal bonds and residual interest tax exempt bonds (inverse floaters), whose interest rates bear an inverse relationship to the interest rate on another security or the value of an index. PIMCO Corporate Opportunity Fund may purchase and write (sell) put and call options. The Fund may sell options on the United States Treasury futures and other fixed-income instruments. PIMCO Corporate Opportunity Fund invests in various industries, including airlines, banking, energy, financial services, food and beverage, hotels/gaming, oil and gas, paper/paper products, telecommunications and utilities. The Fund's investment manager is Allianz Global Investors Fund Management LLC, which is an indirect wholly owned subsidiary of Allianz Global Investors of America L.P. PIMCO Corporate Opportunity Fund's sub-advisor is Pacific Investment Management Company LLC.
Advisors' Opinion:- [By Dan Caplinger]
Lesson 1: Income is king.
A look at the four funds trading at the highest premiums to net asset value reveals a common thread: They're all focused on maximizing income. What's interesting, though, is that they use different methods to reach the same ends. Among the three PIMCO funds, PIMCO High Income (NYSE: PHK ) looks largely to the high-yield bond market for its holdings, while PIMCO Corporate & Income Opportunities (NYSE: PTY ) has a somewhat lower distribution rate but has a sizable allocation to investment-grade debt. The fund with the highest premium, PIMCO Global StocksPLUS, uses futures contracts to add stock exposure to its portfolio of income-producing bonds. Finally, BlackRock Virginia Municipal Bond rounds out the top four with its tax-free bond portfolio.
Top 5 Warren Buffett Stocks To Invest In Right Now: Insys Therapeutics Inc (INSY)
Insys Therapeutics, Inc., incorporated on June 15, 1990, is a pharmaceutical company that develops and seeks to commercialize pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The Company�� pharmaceuticals portfolio consists of one approved product and a number of product candidates targeting cancer-supportive care and cancer therapy. The Company�� product candidate includes Subsys, Dronabinol SG Capsule, Dronabinol RT Capsule, Dronabinol Oral Solution, Dronabinol Inhalation Device, and Dronabinol IV Solution. The Company is also developing cancer therapeutics, which is LEP-ETU, a formulation of paclitaxel, the active ingredient in the cancer drugs Taxol and Abraxane. On August 19, 2011, the Food & Drug Administration (FDA) approved its Dronabinol SG Capsule product, a generic equivalent to Marinol, for the treatment of chemotherapy induced nausea and vomiting (CINV), and anorexia associated with weight loss in patients with acquired immune deficiency syndrome (AIDS).
Subsys
The Company's Subsys is a single-use product that delivers fentanyl, an opioid analgesic, in seconds for transmucosal absorption underneath the tongue. Subsys is a transmucosal product to show pain relief when measuring the sum of pain intensity difference at five minutes in a Phase 3 breakthrough cancer pain (BTCP) clinical trial using fentanyl.
Dronabinol Product Family
The Company has an approved dronabinol product and is developing several dronabinol product candidates for the treatment of CINV and appetite stimulation in patients with AIDS, as well as other indications where dronabinol could have potential therapeutic benefits. Dronabinol, the active ingredient in Marinol, is a synthetic cannabinoid whose chemical name is delta-9-tetrahydrocannabinol (THC). Its portfolio consists of its Dronabinol SG Capsule product and Dronabinol RT Capsule product candidate, which are intended to be generic equi! valents to Marinol, in addition to three formulations, including Dronabinol Oral Solution. Dronabinol SG Capsule is a dronabinol soft gelatin capsule intended to be a generic equivalent to Marinol. Dronabinol RT Capsule is a dronabinol soft gel capsule that is stable at room temperature. Dronabinol Oral Solution is a ynthetic THC in an oral liquid formulation.
Cancer Therapeutics
In addition to its cancer-supportive care products, the Company intends to develop cancer therapeutics targeting limitations of existing commercial products. LEP-ETU, it advanced cancer therapeutic, is a NeoLipid liposomal, or microscopic membrane-like structure created from lipids, formulation that incorporates paclitaxel. LEP-ETU completed a Phase 2 clinical trial of 70 patients with metastatic breast cancer.
The Company competes with Cephalon, Inc., BioDelivery Sciences International, Inc., ProStrakan Group plc, Nycomed International Management GmbH, Archimedes Pharma Ltd., TEVA Pharmaceuticals USA, Watson Pharmaceuticals, Inc., AcelRx Pharmaceuticals, Inc., Akela Pharma Inc., Abbott Laboratories, Pharmaceutical International, Inc., Par Pharmaceutical Companies Inc., sanofi-aventis, Eisai Inc., Helsinn Group, Roche Holding AG, Par Pharmaceutical Companies Inc., GlaxoSmithKline plc, ProStrakan Group plc, Merck & Co, GW Pharmaceutical, A.P. Pharma, Inc., Aphios Corp., Roche Holding, Tesaro, Inc., Cornerstone Pharmaceutical, Inc., Bristol-Myers Squibb, Celgene Corporation, Laboratories, Amgen Inc., AstraZeneca PLC., Bayer AG, Biogen Idec Inc., Eisai Co., Ltd., F. Hoffmann- LaRoche Ltd., Johnson and Johnson, Merck and Co., Inc., Novartis AG, Onyx Pharmaceuticals Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of INSYS Therapeutics (NASDAQ: INSY) were down 15.94 percent to $38.00 after the company received subpoena from Office of Inspector General.
Top 5 Warren Buffett Stocks To Invest In Right Now: Epazz Inc (EPAZ)
EPAZZ, Inc., incorporated on March 23, 2000, develops a Web portal infrastructure operating system product called BoxesOS v3.0. The Company offers seven primary product lines. The Epazz BoxesOS v3.0 product is offered through Epazz, Inc., the Desk/Flex Software product is offered through Desk Flex, Inc., the Agent Power product is offered through Professional Resource Management, Inc., the AutoHire software is offered through Epazz, Inc., IntelliSys offers the Integrated Plant Management Control (IPMC) software product, K9 Bytes offers a series of Point of Sale software products for pet care, boarding and retail pet stores. In July 2012, the Company acquired K9 Bytes Software. In August 2012, the Company acquired MS Health Software Corporation (MS Health), a cloud-based solution for behavioral healthcare, mental health and social services providers.
BoxesOS provides a Web portal infrastructure operating system designed to satisfaction of key stakeholders (students, faculty, alumni, employees, and clients). BoxesOS creates sources of revenue for Alumni Associations and Non-Profit organizations through utilizing a Web platform to conduct e-commerce and provides e-commerce tools for small businesses to easily create my accounts for their customers. BoxesOS can also link a college or university's resources with the business community by allowing businesses to better train their employees by utilizing courseware development from higher education institutions.
Epazz BoxesOS v3.0
Epazz BoxesOS v3.0 (Web Infrastructure Operating System) is the Company's flagship product. Epazz BoxesOS integrates with each organization's back-end systems and provides a customizable personal information system for each stakeholder. The Company's Services include Single sign-on, which provides a single-sign-on with security procedure to protect users' information and identity; Course Management System, which manages distance, traditional courses and Calendar; Enterprise Website Content Man! agement, which manages public sites with multi contributors; Integration Management Services, which integrated into Enterprise Resource Planning (ERP) and Mainframes; E-mail Management, which is an e-mail server and Web client; Instant Messenger Services, which is an instant messaging and alerts; Customer Relationship Management, which includes prospective students and alumni; Calendar/Scheduler Management, which includes event directory, groupware, and personal calendar; Administrative Support Services, which is an online payment services, and Business Services, which includes facility Management and Online Bookstore.
AutoHire Software
The AutoHire system provides a tool to power career centers, post job ads to sites and job boards, and to collect resumes online. One features of the AutoHire system is the interactive question and online screening and ranking system. The interactive question system provides a means for the client to maintain their own library of questions and to attach selected questions to job opportunities posted. Responses obtained can be used to screen and rank candidates to permit hiring managers to focus their attention on only the most suitable candidates.
Desk Flex Software
DFI developed the Desk/Flex Software (Desk/Flex) to enhance the value of businesses' real estate investments and modernize their office space. Desk/Flex lets businesses make better use of office space restrictions by enabling employees to instantly access their workstation tools from multiple areas in and outside of the office. Desk/Flex lets employees reserve space in advance or claim space instantly. It adjusts the telephone switch (Private Branch Exchange (PBX)) so that calls ring at the desk du jour, or go directly to voice mail when a worker is not checked in. Key Features of Desk/Flex include Quick and Easy Check-In, Point-and-Click Floor Maps, PBX Interaction, Web Browser and Local Kiosk Access, Advance Reservations and Occupancy Reports. Desk/Flex i! s respons! ive to office size and needs, servicing small to large businesses. Desk/Flex can be configured to administer a single site or multiple sites locally or remotely. Desk/Flex has full integration capabilities with both Nortel and Avaya, which combined represent the majority of the telecommunications and inbound automatic call distributor (ACD) market.
Agent Power Software
Agent Power Software (Agent Power) is Professional Resource Management, Inc.�� (PRMI's) software line. Agent Power is a suite of six applications. The applications feature workforce management components, which include planning and scheduling; agent adherence; agent performance; automatic call distributor (ACD) group performance; real-time agent status, and info screen. All modules of Agent Power have full integration capabilities with Nortel, Avaya, and ROLM ACDs, and the Planning and Scheduling module works with any modern ACD system.
IntelliSys Software
IntelliSys developed the Integrated Plant Management Control (IPMC) Software, which is a software system design for water and wastewater facility management. IPMC is the technology-based strategy for optimizing operations by automatically collecting, managing, organizing and disseminating information for the operations, management, laboratory, maintenance, and engineering functions.
Advisors' Opinion:- [By James E. Brumley]
It's probably a pretty safe bet that Epazz Inc. (OTCMKTS:EPAZ) isn't a familiar name to most long-term investors. For that matter, EPAZ isn't even a familiar name to short-term traders. Both groups may want to put the stock on their radar though (for different reasons), as the recent action evident on the chart suggests something is brewing here.
No comments:
Post a Comment